Univ

ersit

y of

Uta

h Ex

ecut

ive

Educ

atio

n16

45 E

. Cam

pus C

ente

r Dr.

CRC

C 1

25Sa

lt La

ke C

ity, U

T 84

112

801-

587-

7273

Exec

Ed@

utah

.ed

u

BioVenturesa joint effort by the

&CENTER FOR Medical Innovation

Biodesign from Beginning to EndWhether taken as a stand-alone certificate program, or as part of a focused elective track for any of our current MBA offerings, the BioVentures program provides a detailed guide to the life science product development process, from conception to commercialization.

Every class includes:• Lectures by award-winning faculty• Real-world case study analysis• Seminars by leaders in the field

CME CREDITS AVAILABLE1 SEMESTER

=44 CME CREDITS

Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

Accreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

The Format

To learn more about any of our corporate programs, visit us online or call.

For more info and to register, go to:

HealthSciences.Utah.edu/center-for-medical-innovation/801-587-7281

ExecEd.Eccles.Utah.edu801-587-7273

2017 Class Days:• January 14th and 28th• February 11th and 25th• March 11th and 25th• April 8th and 22nd

Class Breakdown

Price$9,000 per attendee per semester

0.5 Hours - Break

1.5 Hours - Industry Leader led Seminar

4 Hours - Lecture and Case Study Analysis

Each semester is made up of eight six-hour blocks taught every other Saturday.

The two parts of the program are taught as separate progressive semesters.

BioVentures IIBioVentures II focuses on the later stages of the life sciences product development lifecycle.The BioVentures II curriculum is dedicated to creating a compelling value proposition and strategic approaches to regulatory compliance, marketing, capital acquisition and integrated product launch models.

Course Objectives• Students will gain competency in the methodology of strategic

clinical problem solving through a lecture-based format with enhancement of the foundational knowledge through interactive case study discussions.

• Students will learn the core elements of life science industry product development including clinical trials requirements, regulatory strategy and compliance, integrated product launch and competitive advantage analysis, and business plan development.

• Students will gain an appreciation of the pitfalls encountered in real world application of the clinical innovation process through firsthand accounts of case studies presented by experienced professionals who have successfully navigated the process.

• Students will learn the intricacies and challenges of market analysis and business plan development involved in the clinical introduction of new medical technologies.

Curricular Elements• Product Research and Development• Intellectual Property Strategies• Regulatory Strategy and Compliance• Quality and Process Management• Manufacturing Strategies • Clinician Training and Post-Market Studies • Sales and Distribution Strategies• Competitive Landscape Analysis• Business Models, Payer Engagement and Reimbursement

Strategies• Strategic Alignment and Product Launch • Capital Acquisition, Licensing and Strategic Partnerships

BioVentures IBioVentures I focuses on the early stages of the product development lifecycle in the life sciences business sector. The BioVentures I curriculum is dedicated to understanding clinical problems, solution creation and early stage product development designed around regulatory and stakeholder requirements. Each student will be given a unique clinical shadowing opportunity guided by a University of Utah clinician to conduct a clinical observation in the healthcare environment.

Course Objectives• Students will gain competency in the methodology of strategic

clinical problem solving through a lecture-based format with enhancement of the foundational knowledge through interactive case study discussions.

• Students will learn and retain the core elements of early product development through needs finding, ethnographic research, regulatory requirements, prototype design, concept generation and refinement, market opportunity and segmentation analysis.

• Students will learn to identify and assess ethical issues associated with innovating clinical technologies and the resources available to ensure ethical standards are appropriately applied to the innovation process.

• Students will gain an appreciation of the pitfalls encountered in real world application of the clinical innovation process through firsthand accounts of case studies presented by experienced professionals who have successfully navigated the process.

• Students will learn the intricacies and challenges of market analysis and business plan development involved in the clinical introduction of new medical technologies.

Curricular Elements• Clinical Immersion, Needs Finding and Ethnographic Research• Disease State Fundamentals and Treatment Landscape Analysis• Stakeholder and Market Analysis • Opportunity and Financial Modeling• Intellectual Property Fundamentals• Design Processes and Prototype Development• Regulatory Fundamentals, Hazard Analysis and Risk Management• Bench Testing, Animal Studies, Clinical Trials and Ethics • Human Factors and Usability Testing• Advocacy and Promotion--Developing Key Opinion Leaders• Healthcare Reimbursement Fundamentals

UtahBioVentures.com